<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sayers A</submitter><funding>MRC Fellowship</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>e014041</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5577889</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(7)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>This article reviews and compares four commonly used approaches to assess patient responsiveness with a treatment or therapy (return to normal (RTN), minimal important difference (MID), minimal clinically important improvement (MCII), OMERACT-OARSI [Outcome Measures in Rheumatology-Osteoarthris Reseach Society International] (OO)) and demonstrates how each of the methods can be formulated in a multilevel modelling (MLM) framework.&lt;h4>Design&lt;/h4>Cohort study.&lt;h4>Setting&lt;/h4>A cohort of patients undergoing total hip and knee replacement were recruited from a single UK National Health Service hospital.&lt;h4>Population&lt;/h4>400 patients from the Arthroplasty Pain Experience cohort study undergoing total hip (n=210) and knee (n=190) replacement who completed the Intermittent and </pubmed_abstract><journal>BMJ open</journal><pubmed_title>A unified multi-level model approach to assessing patient responsiveness including; return to normal, minimally important differences and minimal clinically important improvement for patient reported outcome measures.</pubmed_title><pmcid>PMC5577889</pmcid><funding_grant_id>RP-PG-0407-10070</funding_grant_id><funding_grant_id>MR/L01226X/1</funding_grant_id><funding_grant_id>NF-SI-0515-10048</funding_grant_id><pubmed_authors>Sayers A</pubmed_authors><pubmed_authors>Gooberman-Hill R</pubmed_authors><pubmed_authors>Beard D</pubmed_authors><pubmed_authors>Dawson J</pubmed_authors><pubmed_authors>Wylde V</pubmed_authors><pubmed_authors>Blom AW</pubmed_authors><pubmed_authors>Price A</pubmed_authors><pubmed_authors>Lenguerrand E</pubmed_authors></additional><is_claimable>false</is_claimable><name>A unified multi-level model approach to assessing patient responsiveness including; return to normal, minimally important differences and minimal clinically important improvement for patient reported outcome measures.</name><description>&lt;h4>Objective&lt;/h4>This article reviews and compares four commonly used approaches to assess patient responsiveness with a treatment or therapy (return to normal (RTN), minimal important difference (MID), minimal clinically important improvement (MCII), OMERACT-OARSI [Outcome Measures in Rheumatology-Osteoarthris Reseach Society International] (OO)) and demonstrates how each of the methods can be formulated in a multilevel modelling (MLM) framework.&lt;h4>Design&lt;/h4>Cohort study.&lt;h4>Setting&lt;/h4>A cohort of patients undergoing total hip and knee replacement were recruited from a single UK National Health Service hospital.&lt;h4>Population&lt;/h4>400 patients from the Arthroplasty Pain Experience cohort study undergoing total hip (n=210) and knee (n=190) replacement who completed the Intermittent and </description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jul</publication><modification>2026-05-05T23:38:41.154Z</modification><creation>2019-03-26T22:45:42Z</creation></dates><accession>S-EPMC5577889</accession><cross_references><pubmed>28733296</pubmed><doi>10.1136/bmjopen-2016-014041</doi></cross_references></HashMap>